港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

藥明合聯

41.150

-1.700-3.97%

成交量：1,177.16萬

成交額：4.82億

市值：494.21億

市盈率：43.27

高：42.550

開：41.600

低：39.650

收：42.850

資料載入中...

總覽公司新聞公告

港股異動 | 藥明合聯(02268)盤中漲超8% 公司去年利潤能力迅速提升創新藥物項目增長穩健

藥明合聯03月31日主力淨流出637萬元散户資金買入

建銀國際：升藥明合聯(02268)目標價至52港元維持評級“跑贏大市”

【建銀國際：升藥明合聯目標價至52港元基本面及展望更明朗】建銀國際的研究報告指，藥明合聯去年及去年下半年的業績勝預期，創新藥物項目的增長穩健。該行將公司今明兩年的總收入預測分別上調3%及4%，至57億元人民幣及79億元人民幣，升今年經調整盈利上調2%至15億元人民幣。該行對公司今年的收入增長預測為按年41%，高過公司指引的按年35%；將目標價由43港元升至52港元，維持評級“跑贏大市”。

大行評級｜建銀國際：上調藥明合聯目標價至52港元維持“跑贏大市”評級

建銀國際：升藥明合聯目標價至52港元基本面及展望更明朗

《大行》建銀國際升藥明合聯(02268.HK)目標價至52元基本面及展望更明朗

阿斯达克财经

藥明合聯03月28日主力淨流入397萬元散戶資金拋售

美銀證券：重申對金蝶國際“買入”評級目標價上調至14.2港元

智通财经网

中金：藥明合聯訂單增長趨勢依然強勁維持“跑贏行業”評級

中金：藥明合聯(02268)訂單增長趨勢依然強勁維持“跑贏行業”評級

港股生物醫藥股集體走強，榮昌生物(09995.HK)漲超9%，藥明生物(02269.HK)漲超7%，藥明合聯(02268

《大行》中金升藥明合聯(02268.HK)目標價至45元訂單維持強勁增長

阿斯达克财经

《股市簡訊》中國藥明合聯一度跳漲8%，富瑞上調目標價因在手訂單量強勁增長

里昂：升藥明合聯目標價至47.3港元維持“跑贏大市評級”

異動解讀 | 藥明合聯盤中大漲8%，業績超預期獲多家大行上調目標價

異動解讀 | 藥明合聯盤中大漲8%，業績亮眼獲分析師上調目標價

藥明合聯高漲逾6% 績後獲多家大行上調目標價

《大行》里昂升藥明合聯(02268.HK)目標價至47.3元去年業績符預期

阿斯达克财经

小摩：升藥明合聯(02268)目標價至46港元評級“增持”

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02268/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"藥明合聯","latestPrice":41.15,"timestamp":1743667696033,"preClose":42.85,"halted":0,"volume":11771578,"delay":0,"floatShares":1201000000,"shares":1201000000,"eps":0.9510180990973479,"marketStatus":"休市中","change":-1.7,"latestTime":"04-03 16:08:16","open":41.6,"high":42.55,"low":39.65,"amount":482354622,"amplitude":0.067678,"askPrice":41.2,"askSize":500,"bidPrice":41.15,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":0.8844111999362468,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":42.85,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.5754415858536063,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1201000000,"roa":"7.19%","roe":"17.69%","lyrEps":0.951018,"volumeRatio":0.5754415858536063,"shares":1201000000,"dividePrice":0,"high":42.55,"amplitude":0.067678,"preClose":42.85,"low":39.65,"week52Low":14.08,"pbRate":"6.99","psRate":"11.45","week52High":49.5,"institutionHeld":0,"latestPrice":41.15,"committee":0.92,"eps":0.9510180990973479,"divideRate":0,"volume":11771578,"delay":0,"ttmEps":0.8844111999362468,"open":41.6,"prevYearClose":30.65,"prevWeekClose":45.7,"prevMonthClose":44.4,"prevQuarterClose":44.4,"fiveDayClose":44.5,"twentyDayClose":34.8,"sixtyDayClose":29.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524844661","title":"港股異動 | 藥明合聯(02268)盤中漲超8% 公司去年利潤能力迅速提升 創新藥物項目增長穩健","url":"https://stock-news.laohu8.com/highlight/detail?id=2524844661","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524844661?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 10:18","pubTimestamp":1743473922,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明合联盘中涨超8%，截至发稿，涨8.56%，报48.05港元，成交额1.02亿港元。消息面上，近日，药明合联披露2024年业绩。建银国际发布研报称，药明合联去年及去年下半年的业绩胜预期，创新药物项目的增长稳健。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1272381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","159992","BK1161","BK1574","BK1141","06978","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2523799291","title":"藥明合聯03月31日主力淨流出637萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2523799291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523799291?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 16:16","pubTimestamp":1743408981,"startTime":"0","endTime":"0","summary":"03月31日, 药明合联股价跌2.84%，报收44.40元，成交金额2.27亿元，换手率0.43%，振幅5.36%，量比0.79。药明合联今日主力资金（超大单+大单）净流出637万元，上一交易日主力净流入397万元。该股近5个交易日上涨5.46%，主力资金累计净流出4364万元；近20日主力资金累计净流出4409万元，其中净流出天数为12日。该股主力净额占比0.01%（主力资金净额/流通市值），港股市场排名2326/2651。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165851a4485609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165851a4485609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2523995696","title":"建銀國際：升藥明合聯(02268)目標價至52港元 維持評級“跑贏大市”","url":"https://stock-news.laohu8.com/highlight/detail?id=2523995696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523995696?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 11:09","pubTimestamp":1743390597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，建银国际发布研报称，药明合联(02268)去年及去年下半年的业绩胜预期，创新药物项目的增长稳健。该行将公司今明两年的总收入预测分别上调3%及4%，至57亿元人民币及79亿元人民币，升今年经调整盈利上调2%至15亿元人民币。该行对公司今年的收入增长预测为同比41%，高过公司指引的同比35%；将目标价由43港元升至52港元，维持评级“跑赢大市”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1271371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2523519955","title":"【建銀國際：升藥明合聯目標價至52港元 基本面及展望更明朗】建銀國際的研究報告指，藥明合聯去年及去年下半年的業績勝預期，創新藥物項目的增長穩健。該行將公司今明兩年的總收入預測分別上調3%及4%，至57億元人民幣及79億元人民幣，升今年經調整盈利上調2%至15億元人民幣。該行對公司今年的收入增長預測為按年41%，高過公司指引的按年35%；將目標價由43港元升至52港元，維持評級“跑贏大市”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2523519955","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523519955?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 10:53","pubTimestamp":1743389592,"startTime":"0","endTime":"0","summary":"建银国际的研究报告指，药明合联去年及去年下半年的业绩胜预期，创新药物项目的增长稳健。该行将公司今明两年的总收入预测分别上调3%及4%，至57亿元人民币及79亿元人民币，升今年经调整盈利上调2%至15亿元人民币。该行对公司今年的收入增长预测为按年41%，高过公司指引的按年35%；将目标价由43港元升至52港元，维持评级“跑赢大市”。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/31105349163796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159992","02268","06978"],"gpt_icon":0},{"id":"2523955532","title":"大行評級｜建銀國際：上調藥明合聯目標價至52港元 維持“跑贏大市”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2523955532","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523955532?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 10:49","pubTimestamp":1743389382,"startTime":"0","endTime":"0","summary":"建银国际发表研究报告指，药明合联去年及去年下半年的业绩胜预期，创新药物项目的增长稳健。该行将公司今明两年的总收入预测分别上调3%及4%，至57亿元及79亿元，升今年经调整盈利上调2%至15亿元。该行对公司今年的收入增长预测为按年增长41%，高过公司指引的按年增长35%；将目标价由43港元上调至52港元，维持“跑赢大市”评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/31104949163798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02268"],"gpt_icon":0},{"id":"2523953277","title":"建銀國際：升藥明合聯目標價至52港元 基本面及展望更明朗","url":"https://stock-news.laohu8.com/highlight/detail?id=2523953277","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523953277?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 10:48","pubTimestamp":1743389311,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2488822045.USD","BK1574","SG9999014674.SGD","BK1141","159992","02268","06978","BK1161"],"gpt_icon":0},{"id":"2523095363","title":"《大行》建銀國際升藥明合聯(02268.HK)目標價至52元 基本面及展望更明朗","url":"https://stock-news.laohu8.com/highlight/detail?id=2523095363","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523095363?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 10:21","pubTimestamp":1743387660,"startTime":"0","endTime":"0","summary":"建银国际的研究报告指，药明合联(02268.HK) 去年及去年下半年的业绩胜预期，创新药物项目的增长稳健。该行将公司今明两年的总收入预测分别上调3%及4%，至57亿元人民币及79亿元人民币，升今年经调整盈利上调2%至15亿元人民币。该行对公司今年的收入增长预测为按年41%，高过公司指引的按年35%；将目标价由43元升至52元，维持评级“跑赢大市”。(vc/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-28 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1430076/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2522654440","title":"藥明合聯03月28日主力淨流入397萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2522654440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522654440?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 16:17","pubTimestamp":1743149830,"startTime":"0","endTime":"0","summary":"03月28日, 药明合联股价涨2.70%，报收45.70元，成交金额2.55亿元，换手率0.47%，振幅4.16%，量比0.60。药明合联今日主力资金（超大单+大单）净流入397万元，上一交易日主力净流出2213万元。该股近5个交易日上涨7.49%，主力资金累计净流出3084万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3815万元，其中净流出天数为12日。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328170012a4451d50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328170012a4451d50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2522340108","title":"美銀證券：重申對金蝶國際“買入”評級 目標價上調至14.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522340108","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522340108?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 17:06","pubTimestamp":1743066415,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美银证券发布研报称，上调对金蝶国际(00268)目标价，由12港元上调至14.2港元，把云收入的预测市盈率目标由6倍上调至7倍，反映经常性收入占比上升。鉴于经常性收入占比提升带来稳健收入增长，盈利能力改善及自由现金流好转，以及人工智能变现潜力，该行重申对金蝶“买入”评级。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["161027","02268","00268"],"gpt_icon":0},{"id":"2522343295","title":"中金：藥明合聯訂單增長趨勢依然強勁 維持“跑贏行業”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2522343295","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522343295?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 15:32","pubTimestamp":1743060760,"startTime":"0","endTime":"0","summary":"中金发布研报称，药明合联2024年业绩符合预期，收入同比增长90.8%，净利润增长277.2%，毛利率同比提升4.2个百分点至30.6%，净利率亦提升13个百分点至26.4%，利润能力迅速提升，考虑到订单增长趋势依然强劲，将2025年和2026年经调整净利润预测上调7.4%和12.2%，维持“跑赢行业”评级。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032715460994c28f1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032715460994c28f1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268"],"gpt_icon":0},{"id":"2522310244","title":"中金：藥明合聯(02268)訂單增長趨勢依然強勁 維持“跑贏行業”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2522310244","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522310244?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 15:17","pubTimestamp":1743059856,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，药明合联(02268)2024年业绩符合预期，收入同比增长90.8%，净利润增长277.2%，毛利率同比提升4.2个百分点至30.6%，净利率亦提升13个百分点至26.4%，利润能力迅速提升，考虑到订单增长趋势依然强劲，将2025年和2026年经调整净利润预测上调7.4%和12.2%，维持“跑赢行业”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2522314105","title":"港股生物醫藥股集體走強，榮昌生物(09995.HK)漲超9%，藥明生物(02269.HK)漲超7%，藥明合聯(02268","url":"https://stock-news.laohu8.com/highlight/detail?id=2522314105","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522314105?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:39","pubTimestamp":1743057558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0326950275.SGD","LU1242518857.USD","LU2045819591.USD","LU2488822045.USD","BK1589","LU2328871848.SGD","BK0174","LU0417516902.SGD","YANG","LU1064130708.USD","07226","LU0456842615.SGD","HSCEI","LU1064131003.USD","BK1161","LU0456846285.SGD","LU1688375341.USD","BK0028","03347","LU0572944931.SGD","LU0052750758.USD","LU1720050803.USD","LU2125910500.SGD","LU1997245177.USD","LU0823426308.USD","LU0456827905.SGD","BK1576","603259","399441","BK1574","HSTECH","LU0140636845.USD","LU0348735423.USD","BK1583","300347","IE00B0JY6N72.USD","02268","BK4614","LU0516423174.USD","161726","SG9999014674.SGD","09995","688331","02269","LU2148510915.USD","LU1820825898.SGD","LU0039217434.USD","BK1141","02359"],"gpt_icon":0},{"id":"2522313066","title":"《大行》中金升藥明合聯(02268.HK)目標價至45元  訂單維持強勁增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2522313066","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522313066?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 12:58","pubTimestamp":1743051480,"startTime":"0","endTime":"0","summary":"中金发表研报指，药明合联(02268.HK) 2024年业绩符合预期，收入按年增长90.8%，净利润增长277.2%，毛利率按年提升4.2个百分点至30.6%，净利率亦提升13个百分点至26.4%，利润能力迅速提升，考虑到订单增长趋势依然强劲，将2025年和2026年经调整净利润预测上调7.4%和12.2%，目标价上调至45元，维持“跑赢行业”评级。(gc/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-27 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1428751/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2522900133","title":"《股市簡訊》中國藥明合聯一度跳漲8%，富瑞上調目標價因在手訂單量強勁增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2522900133","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522900133?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 12:26","pubTimestamp":1743049583,"startTime":"0","endTime":"0","summary":"《股市简讯》中国药明合联一度跳涨8%，富瑞上调目标价因在手订单量强劲增长* 从药明生物2269.HK分拆上市的中国药明合联2268.HK周四早盘一度劲升8%，早市收高7.2%。* 美国投行富瑞在报告中表示，将药明合联的目标价由41港元上调至60港元，以反映在手订单量的强劲增长和高可见度；该公司的新加坡生产基地将在2025年底开始生产。* 药明合联今年迄今劲涨46.3%，同期恒生指数.HSI大幅上扬18.3%。* 恒生香港上市生物科技指数.HSHKBIO早盘收涨4.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL3T3QA0CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2522909813","title":"里昂：升藥明合聯目標價至47.3港元 維持“跑贏大市評級”","url":"https://stock-news.laohu8.com/highlight/detail?id=2522909813","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522909813?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 12:01","pubTimestamp":1743048060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　里昂发布研报称，药明合联（02268）去年下半年收入和调整后净利润分别同比增长111%和227%，符合市场共识，并超出2025年1月发布的盈利预告。公司预计2025年收入增长35%（指引不变），调整后净利润率与2024年相近。该行将2025财年至2027财年的收入预测小幅调整0-1%，以反映2024年业绩的更新，将目标价从44.3港元上调至47.3港元，维持“跑赢大市评级”。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-27/doc-ineraiqt8192147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268"],"gpt_icon":0},{"id":"1130851258","title":"異動解讀 | 藥明合聯盤中大漲8%，業績超預期獲多家大行上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1130851258","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130851258?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 10:54","pubTimestamp":1743044071,"startTime":"0","endTime":"0","summary":"周四盘中，药明合联股价强劲上涨，涨幅达8%，引发市场广泛关注。这波涨势主要受到公司发布的2024年度财报以及多家知名投行上调目标价的推动。这一亮眼的业绩表现超出市场预期，成为推动股价上涨的主要因素之一。花旗将药明合联的目标价从43港元上调至46港元，并给予\"买入\"评级。这些积极的分析报告进一步增强了投资者对药明合联未来发展的信心，推动其股价大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"1162268592","title":"異動解讀 | 藥明合聯盤中大漲8%，業績亮眼獲分析師上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1162268592","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162268592?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 10:54","pubTimestamp":1743044068,"startTime":"0","endTime":"0","summary":"药明合联今日盘中大涨8%，股价表现强劲。这一涨幅主要受到公司发布的2024年度财报及分析师积极评级的推动。根据公司最新发布的财报显示，药明合联2024年度录得纯利10.7亿元人民币，同比大幅增长277.2%，每股盈利89分。多家大型投资银行对药明合联的前景持乐观态度。摩根大通维持\"增持\"评级，同样将目标价上调至46港元。分析师们普遍认为公司2025财年的销售增长预期可能过于保守，并上调了未来几年的销售预测。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 药明合联盘中大涨8%，业绩亮眼获分析师上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"2522399835","title":"藥明合聯高漲逾6% 績後獲多家大行上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2522399835","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522399835?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 10:37","pubTimestamp":1743043066,"startTime":"0","endTime":"0","summary":"该行认为目标略为过于保守。由于药明合联去年的基数较高，且有强劲的积压订单及新订单，将其今年销售额预测上调约20%，并进一步调升2026年打后的长远销售预测23至24%。该行升集团2025至33年的销售额预测20至24%，该行将药明合联目标价升约30%至46港元，维持“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503271038089724a6ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503271038089724a6ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268"],"gpt_icon":0},{"id":"2522828146","title":"《大行》里昂升藥明合聯(02268.HK)目標價至47.3元  去年業績符預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2522828146","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522828146?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 17:39","pubTimestamp":1742981940,"startTime":"0","endTime":"0","summary":"里昂表示，药明合联(02268.HK) 去年下半年收入和调整后净利润分别按年增长111%和227%，符合市场共识，并超出2025年1月发布的盈利预告。公司预计2025年收入增长35%(指引不变)，调整后净利润率与2024年相近。该行将2025财年至2027财年的收入预测小幅调整0-1%，以反映2024年业绩的更新。该行将目标价从44.3元上调至47.3元。维持“跑赢大市”评级。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-26 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1428354/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2522881738","title":"小摩：升藥明合聯(02268)目標價至46港元 評級“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881738","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881738?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 16:01","pubTimestamp":1742976086,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通发布研报称，药明合联(02268)去年销售及经调整净利润分别同比增长91%及171%，但管理层仍维持2025财年销售同比增长逾35%的指引。该行认为目标略为过于保守。该行表示，由于药明合联去年的基数较高，且有强劲的积压订单及新订单，将其今年销售额预测上调约20%，并进一步调升2026年往后的长远销售预测23至24%。该行升集团2025至33年的销售额预测20至24%，该行将药明合联目标价升约30%至46港元，维持“增持”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5556,"hold":0.0556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1743091200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2025-04-03","current":43.121995,"percent":0.439252,"low":0.407466,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"high":153.052589,"avg":46.164517,"sd":42.328118,"marketCap":49380552191},"quantilePoints":[{"date":"2020-04-09","current":0.444116,"twenty":2.759621,"median":7.82388,"eighty":11.01076,"marketCap":323186685},{"date":"2020-04-17","current":0.446187,"twenty":2.745207,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-24","current":0.446702,"twenty":2.734879,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-29","current":0.44639,"twenty":2.727395,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-05-08","current":0.446161,"twenty":2.71703,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-15","current":0.447931,"twenty":2.704934,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-22","current":0.449375,"twenty":2.687419,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-29","current":0.450088,"twenty":2.678738,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-05","current":0.44683,"twenty":2.666003,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-12","current":0.446873,"twenty":2.652949,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-19","current":0.446059,"twenty":2.62708,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-26","current":0.446464,"twenty":2.610591,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-03","current":0.445777,"twenty":2.573756,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-10","current":0.441566,"twenty":2.54079,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-17","current":0.440865,"twenty":2.474175,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-24","current":0.442598,"twenty":2.408815,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-31","current":0.440015,"twenty":2.351114,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-07","current":0.439541,"twenty":2.260124,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-14","current":0.438441,"twenty":0.452125,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-21","current":0.436461,"twenty":0.449515,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-28","current":0.43308,"twenty":0.448387,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-09-04","current":0.431618,"twenty":0.447817,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-11","current":0.431156,"twenty":0.447535,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-18","current":0.427016,"twenty":0.447373,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-25","current":0.430436,"twenty":0.447153,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-30","current":0.428392,"twenty":0.446995,"median":7.824737,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-09","current":0.422312,"twenty":0.446839,"median":7.815551,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-16","current":0.422486,"twenty":0.446689,"median":7.778238,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-23","current":0.421832,"twenty":0.446509,"median":7.763554,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-30","current":0.421767,"twenty":0.446296,"median":7.728277,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-06","current":0.416892,"twenty":0.446096,"median":7.681665,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-13","current":0.416542,"twenty":0.445828,"median":7.62168,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-20","current":0.413946,"twenty":0.445667,"median":7.588964,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-27","current":0.414916,"twenty":0.445574,"median":7.400318,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-04","current":0.411952,"twenty":0.44527,"median":7.31626,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-11","current":0.41294,"twenty":0.44498,"median":7.224146,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-18","current":0.412272,"twenty":0.444321,"median":7.177259,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-24","current":0.411847,"twenty":0.443892,"median":6.957959,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-31","current":0.411678,"twenty":0.44363,"median":6.764797,"eighty":11.047512,"marketCap":323186685},{"date":"2021-01-08","current":0.408416,"twenty":0.443491,"median":6.650061,"eighty":11.067383,"marketCap":323186685},{"date":"2021-01-15","current":0.408583,"twenty":0.442598,"median":6.55329,"eighty":11.072351,"marketCap":323186685},{"date":"2021-01-22","current":0.408755,"twenty":0.442234,"median":6.512372,"eighty":11.072351,"marketCap":323186685},{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191}],"updateTime":1743787920313}}}